Insular O
and O
Cingulate O
Attenuation O
during O
Decision O
Making O
is O
associated O
with O
Future O
Transition O
to O
Stimulant O
Use O
Disorder O
Aims O
To O
understand O
processes O
placing O
individuals O
at O
risk O
for O
stimulant O
( O
amphetamine O
and O
cocaine O
) O
use O
disorder O
. O

Design O
Longitudinal O
study O
. O

Setting O
University O
of O
California O
, O
San O
Diego O
Department O
of O
Psychiatry O
, O
USA O
. O

Participants O
Occasional O
stimulant O
users O
( O
OSU O
; O
n=184 O
) O
underwent O
a O
baseline O
clinical O
interview O
and O
a O
functional O
magnetic O
resonance O
imaging O
( O
fMRI O
) O
session O
. O

On O
the O
basis O
of O
a O
follow-up O
clinical O
interview O
completed O
three O
years O
later O
, O
OSU O
( O
n=147 O
) O
were O
then O
categorized O
as O
problem O
stimulant O
users O
( O
PSU O
: O
n=36 O
; O
those O
who O
developed O
stimulant O
use O
disorders O
in O
the O
interim O
) O
or O
desisted O
stimulant O
users O
( O
DSU O
: O
n=74 O
; O
those O
who O
stopped O
using O
) O
. O

OSU O
who O
did O
not O
meet O
criteria O
for O
PSU O
or O
DSU O
( O
n=37 O
) O
were O
included O
in O
dimensional O
analyses O
. O

Measurements O
fMRI O
blood-oxygen-level O
dependent O
( O
BOLD O
) O
contrast O
percent O
signal O
change O
from O
baseline O
collected O
during O
a O
Paper-Scissors-Rock O
task O
was O
examined O
during O
three O
decision O
making O
conditions O
, O
those O
resulting O
in O
: O
( O
1 O
) O
wins O
, O
( O
2 O
) O
ties O
, O
and O
( O
3 O
) O
losses O
. O

These O
data O
were O
used O
as O
dependent O
variables O
in O
categorical O
analyses O
comparing O
PSU O
and O
DSU O
as O
well O
as O
dimensional O
analyses O
including O
interim O
drug O
use O
as O
predictors O
, O
controlling O
for O
baseline O
drug O
use O
. O

Findings O
PSU O
exhibited O
lower O
anterior O
cingulate O
, O
middle O
insula O
, O
superior O
temporal O
, O
inferior O
parietal O
, O
precuneus O
and O
cerebellum O
activation O
than O
DSU O
across O
all O
three O
conditions O
( O
significant O
brain O
clusters O
required O
> O
19 O
neighboring O
voxels O
to O
exceed O
F O
( O
1,108 O
) O
=5.58 O
, O
p O
< O
.01 O
two-tailed O
; O
all O
Cohen O
’ O
s O
d O
> O
.83 O
) O
. O

Higher O
interim O
marijuana O
use O
was O
linked O
to O
lower O
precentral O
and O
superior O
temporal O
activation O
during O
choices O
resulting O
in O
wins O
( O
> O
19 O
neighboring O
voxels O
to O
exceed O
t=2.61 O
, O
p O
< O
.01 O
two-tailed O
; O
R2 O
change O
> O
.11 O
) O
. O

Conclusions O
Individuals O
who O
transition O
from O
stimulant O
use O
to O
stimulant O
use O
disorder O
appear O
to O
show O
alterations O
in O
neural O
processing O
of O
stimulus O
valuation O
and O
outcome O
monitoring O
, O
patterns O
also O
evident O
in O
chronic O
stimulant O
use O
disorder O
. O

Attenuated O
anterior O
cingulate O
and O
insular O
processing O
may O
constitute O
a O
high-risk O
neural O
processing O
profile O
, O
which O
could O
be O
used O
to O
calculate O
risk O
scores O
for O
individuals O
experimenting O
with O
stimulants O
. O

Methods O
Design O
Figure O
1 O
illustrates O
the O
longitudinal O
study O
design O
: O
( O
1 O
) O
at O
baseline O
, O
OSU O
completed O
an O
interview O
to O
evaluate O
clinical O
diagnoses O
and O
determine O
initial O
drug O
use O
patterns O
, O
and O
a O
neuroimaging O
session O
; O
and O
( O
2 O
) O
three O
years O
later O
, O
OSU O
completed O
a O
follow-up O
interview O
to O
determine O
changes O
in O
clinical O
status O
and O
patterns O
of O
drug O
use O
. O

Participants O
The O
study O
protocol O
was O
approved O
by O
the O
University O
of O
California O
, O
San O
Diego O
institutional O
review O
board O
and O
complied O
with O
the O
Declaration O
of O
Helsinki O
. O

Students O
at O
local O
universities O
were O
recruited O
via O
internet O
ads O
, O
newspapers O
, O
and O
flyers O
; O
OSU O
who O
met O
study O
criteria O
provided O
written O
informed O
consent O
to O
participate O
. O

OSU O
endorsed O
: O
( O
a O
) O
> O
2 O
off-prescription O
uses O
of O
cocaine O
and/or O
pharmaceutical O
stimulants O
( O
amphetamines O
and/or O
methylphenidate O
) O
in O
the O
past O
six O
months O
; O
( O
b O
) O
no O
lifetime O
stimulant O
dependence O
; O
and O
( O
c O
) O
no O
interest O
in O
drug O
treatment O
. O

Baseline O
Interview O
Session O
Lifetime O
DSM-IV O
Axis O
I O
diagnoses O
and O
Axis O
II O
antisocial O
personality O
disorder O
( O
ASPD O
) O
were O
assessed O
by O
the O
Semi-Structured O
Assessment O
for O
the O
Genetics O
of O
Alcoholism O
II O
( O
SSAGA O
II O
) O
( O
see O
for O
participant O
exclusion O
criteria O
) O
. O

Subjects O
also O
completed O
a O
measure O
of O
verbal O
intelligence O
( O
IQ O
) O
as O
well O
as O
the O
Barratt O
Impulsiveness O
Scale O
( O
BIS-11 O
) O
, O
Sensation O
Seeking O
Scale O
( O
SSS O
) O
, O
and O
Beck O
Depression O
Inventory O
( O
BDI O
) O
, O
measures O
indexing O
impulsivity O
, O
sensation O
seeking O
, O
and O
depression O
, O
respectively O
. O

Baseline O
Neuroimaging O
Session O
Overview O
Participants O
were O
instructed O
to O
abstain O
from O
illicit O
substance O
use O
≥ O
72 O
h O
prior O
( O
abstinence O
was O
determined O
by O
urine O
toxicology O
screen O
) O
. O

Subjects O
then O
completed O
the O
PSR O
task O
during O
fMRI O
recording O
after O
engaging O
in O
a O
practice O
version O
of O
the O
task O
outside O
of O
the O
scanner O
. O

PSR O
paradigm O
This O
task O
examines O
how O
individuals O
acquire O
the O
ability O
to O
make O
decisions O
associated O
with O
advantageous O
outcomes O
, O
wherein O
: O
( O
1 O
) O
rock O
beats O
scissors O
; O
( O
2 O
) O
paper O
beats O
rock O
; O
( O
3 O
) O
scissors O
beat O
paper O
. O

Subjects O
were O
instructed O
to O
play O
against O
the O
computer O
and O
attempt O
to O
maximize O
points O
( O
1 O
for O
a O
win O
, O
0 O
for O
a O
tie O
, O
and O
−1 O
for O
a O
loss O
) O
, O
as O
they O
would O
receive O
additional O
payment O
according O
to O
their O
cumulative O
point O
total O
( O
each O
point O
was O
worth O
$ O
1 O
) O
. O

Unknown O
to O
the O
subject O
, O
probability O
of O
beating O
the O
computer O
and O
thus O
being O
reinforced O
( O
e.g. O
, O
subject O
chooses O
scissors O
, O
computer O
selects O
paper O
, O
scissors O
beats O
paper O
, O
subject O
gains O
1 O
point O
) O
was O
predetermined O
. O

A O
total O
of O
120 O
trials O
were O
presented O
( O
six O
blocks O
containing O
20 O
trials O
) O
. O

Within O
each O
block O
, O
the O
three O
possible O
selections O
had O
pre-determined O
probabilities O
of O
having O
a O
winning O
, O
tying O
, O
or O
losing O
outcome O
. O

The O
“ O
preferred O
response O
” O
won O
on O
90 O
% O
of O
trials O
, O
the O
“ O
even O
response O
” O
won O
50 O
% O
of O
the O
time O
, O
and O
the O
“ O
worst O
response O
” O
won O
on O
10 O
% O
of O
trials O
. O

Preferred O
, O
even O
, O
and O
worst O
responses O
were O
switched O
for O
each O
of O
the O
six O
blocks O
. O

Figure O
2A O
illustrates O
an O
example O
of O
one O
trial O
. O

After O
an O
initial O
fixation O
lasting O
2 O
s O
, O
subjects O
saw O
a O
hand O
forming O
paper O
, O
scissors O
, O
and O
rock O
on O
a O
screen O
for O
1 O
s O
and O
heard O
the O
instruction O
“ O
one O
, O
two O
, O
three O
” O
over O
headphones O
. O

At O
3 O
s O
into O
the O
trial O
, O
subjects O
were O
then O
presented O
with O
a O
“ O
Go O
” O
sign O
, O
providing O
the O
cue O
to O
select O
paper O
, O
scissors O
, O
or O
rock O
. O

Subjects O
had O
3.5 O
s O
to O
respond O
, O
after O
which O
the O
trial O
timed O
out O
. O

Upon O
responding O
, O
the O
outcome O
was O
presented O
, O
wherein O
the O
subject O
saw O
the O
computer O
’ O
s O
response O
, O
and O
heard O
“ O
you O
win O
, O
” O
“ O
you O
lose O
, O
” O
or O
“ O
a O
tie O
” O
. O

Nine O
null O
trials O
were O
interspersed O
at O
the O
beginning O
( O
three O
prior O
to O
any O
relevant O
trials O
) O
, O
middle O
( O
three O
prior O
to O
the O
fourth O
block O
) O
, O
and O
end O
of O
the O
task O
( O
three O
after O
all O
relevant O
trials O
were O
completed O
) O
as O
a O
temporal O
jitter O
. O

fMRI O
image O
acquisition O
One O
run O
indexing O
blood O
oxygenation O
level-dependent O
( O
BOLD O
) O
contrast O
was O
collected O
( O
randomized O
fast-event O
related O
design O
) O
using O
a O
Signa O
EXCITE O
( O
GE O
Healthcare O
, O
Milwaukee O
, O
Wisconsin O
) O
3.0 O
Tesla O
scanner O
( O
T2 O
* O
-weighted O
EPI O
scans O
, O
TR=2000 O
ms O
, O
TE=32 O
ms O
, O
FOV=230mm3 O
, O
64×64 O
matrix O
, O
30 O
2.6mm O
axial O
slices O
[ O
1.4 O
mm O
gap O
] O
, O
flip O
angle=90° O
, O
290 O
whole-brain O
TRs O
) O
. O

fMRI O
volume O
acquisitions O
were O
time-locked O
to O
task O
onset O
. O

A O
high-resolution O
T1-weighted O
anatomical O
image O
was O
obtained O
[ O
spoiled O
gradient O
recalled O
( O
SPGR O
) O
, O
TI=450 O
, O
TR=8 O
ms O
, O
TE=3 O
ms O
, O
flip O
angle=12° O
, O
FOV=250mm3 O
, O
192×256 O
matrix O
, O
172 O
sagittally O
acquired O
slices O
with O
1mm O
thickness O
] O
. O

Analysis O
pathway O
specifications O
including O
slice O
timing O
correction O
, O
outlier O
estimation/removal O
, O
and O
motion O
estimation/correction O
are O
detailed O
in O
. O

Multiple O
regressor O
analyses O
A O
deconvolution O
model O
was O
created O
in O
Analysis O
of O
Functional O
Neuroimages O
( O
AFNI O
) O
, O
individualized O
for O
each O
participant O
, O
comparing O
decision-making O
between O
preferred O
, O
even O
, O
and O
worst O
response O
selections O
. O

Each O
subject O
’ O
s O
behavioral O
performance O
determined O
three O
regressors O
of O
interest O
for O
trials O
in O
which O
the O
participant O
selected O
: O
( O
a O
) O
the O
preferred O
response O
, O
( O
b O
) O
the O
tied O
response O
, O
and O
( O
c O
) O
the O
worst O
response O
( O
Figure O
2B O
depicts O
an O
example O
of O
one O
participant O
’ O
s O
performance O
) O
. O

The O
baseline O
for O
this O
model O
consisted O
of O
the O
inter-trial O
interval O
and O
null O
trials O
interspersed O
between O
trial O
blocks O
. O

Regressors O
of O
interest O
were O
generated O
to O
delineate O
conditions O
for O
this O
model O
, O
wherein O
a O
0–1 O
reference O
function O
for O
each O
condition O
was O
convolved O
with O
a O
gamma O
variate O
function O
modeling O
a O
prototypical O
hemodynamic O
response O
( O
6–8 O
s O
delay O
) O
. O

Three O
normalized O
decision-making O
predictors O
( O
brain O
activation O
from O
trial O
onset O
to O
each O
participant O
’ O
s O
behavioral O
selection O
of O
the O
preferred O
, O
even O
, O
and O
worst O
response O
designated O
for O
each O
block O
) O
were O
included O
in O
the O
AFNI O
program O
3dDeconvolve O
, O
controlling O
for O
motion O
as O
well O
as O
baseline O
and O
linear O
drift O
, O
to O
estimate O
goodness O
of O
fit O
between O
model O
estimates O
and O
BOLD O
responses O
for O
each O
subject O
. O

Voxels O
were O
resampled O
into O
4×4×4mm3 O
space O
and O
whole-brain O
voxel-wise O
normalized O
percent O
signal O
change O
( O
PSC O
) O
, O
the O
main O
dependent O
measure O
, O
was O
determined O
by O
dividing O
the O
beta O
coefficient O
for O
each O
of O
the O
predictors O
of O
interest O
( O
preferred O
, O
even O
, O
and O
worst O
responses O
) O
by O
the O
beta O
coefficient O
for O
the O
baseline O
regressor O
and O
multiplying O
by O
100 O
. O

A O
Gaussian O
spatial O
filter O
( O
4mm O
full O
width O
half O
maximum O
; O
FWHM O
) O
was O
used O
to O
spatially O
blur O
PSC O
values O
to O
account O
for O
anatomical O
differences O
and O
this O
output O
was O
then O
normalized O
to O
Talairach O
coordinates O
( O
40×48×38 O
voxel O
coverage O
) O
as O
defined O
by O
AFNI O
’ O
s O
built-in O
atlases O
. O

Individual O
subject O
PSC-scaled O
beta O
weight O
values O
for O
preferred O
, O
even O
, O
and O
worst O
responses O
for O
each O
voxel O
included O
in O
a O
whole-brain O
mask O
( O
comprised O
of O
23775 O
voxels O
) O
was O
extracted O
for O
further O
categorical O
and O
dimensional O
statistical O
analyses O
outlined O
below O
. O

Individual O
voxels O
meeting O
a O
p O
< O
.01 O
significance O
criterion O
as O
a O
result O
of O
these O
statistical O
tests O
( O
linear O
mixed O
models O
and O
regressions O
) O
were O
further O
evaluated O
to O
determine O
whether O
they O
comprised O
a O
significant O
brain O
cluster O
after O
correction O
for O
multiple O
comparisons O
( O
given O
all O
voxels O
included O
in O
the O
whole-brain O
mask O
) O
. O

Leading O
neuroimaging O
programs O
have O
recently O
been O
criticized O
for O
underestimation O
of O
spatial O
autocorrelation O
in O
fMRI O
data O
, O
resulting O
in O
inadequate O
implementation O
of O
correction O
for O
multiple O
comparisons O
when O
determining O
how O
many O
voxels O
are O
required O
to O
comprise O
a O
significant O
brain O
cluster O
. O

As O
a O
consequence O
of O
this O
critique O
, O
we O
revised O
our O
laboratory O
’ O
s O
clustering O
procedure O
. O

First O
, O
the O
updated O
AFNI O
3dFWHMx O
program O
was O
used O
to O
more O
reliably O
estimate O
the O
actual O
autocorrelation O
in O
fMRI O
data O
across O
participants O
( O
.44 O
, O
1.71 O
, O
and O
10.36 O
) O
as O
well O
as O
the O
actual O
smoothness O
present O
in O
the O
data O
after O
blurring O
( O
4.99 O
mm O
) O
. O

Second O
, O
we O
then O
ran O
an O
updated O
version O
of O
AFNI O
’ O
s O
3dClustSim O
that O
takes O
these O
autocorrelation O
values O
into O
account O
given O
our O
voxel O
size O
, O
whole O
brain O
mask O
size O
, O
10,000 O
Monte O
Carlo O
simulations O
, O
and O
two-sided O
thresholding O
with O
an O
overall O
voxel O
p O
statistical O
threshold O
of O
.01 O
and O
a O
corrected O
clusterwise O
alpha O
value O
of O
.01 O
. O

Given O
this O
input O
, O
3dClustSim O
determined O
that O
: O
( O
1 O
) O
our O
data O
smoothness O
approached O
6.20mm O
; O
and O
( O
2 O
) O
> O
19 O
neighboring O
voxels O
( O
or O
> O
1216μL O
) O
were O
required O
to O
comprise O
a O
significant O
brain O
cluster O
; O
this O
voxelwise O
cutoff O
more O
than O
doubles O
the O
size O
of O
the O
cluster O
required O
for O
significance O
given O
similar O
blurring O
parameters O
in O
our O
prior O
work O
( O
8 O
voxels O
) O
. O

Three O
Year O
Follow-Up O
Interview O
Session O
OSU O
were O
contacted O
three O
years O
after O
their O
baseline O
assessment O
( O
Figure O
1 O
) O
. O

Each O
participant O
underwent O
a O
standardized O
interview O
( O
phone O
or O
in-person O
) O
to O
examine O
extent O
of O
drug O
use O
in O
the O
three-year O
interim O
since O
the O
baseline O
interview O
, O
thereby O
allowing O
us O
to O
identify O
subjects O
meeting O
criteria O
for O
new O
stimulant O
user O
groups O
: O
PSU O
or O
DSU O
. O

PSU O
were O
a O
priori O
defined O
by O
: O
( O
1 O
) O
continued O
stimulant O
use O
during O
the O
three-year O
interim O
( O
see O
Table O
1 O
) O
; O
and O
( O
2 O
) O
endorsement O
of O
2+ O
symptoms O
of O
DSM-IV O
amphetamine O
and/or O
cocaine O
abuse O
or O
dependence O
criteria O
occurring O
together O
≥ O
6 O
contiguous O
months O
since O
the O
initial O
visit O
( O
M=4.17 O
symptoms O
; O
SD=2.32 O
; O
range O
: O
2–9 O
) O
. O

Percentage O
of O
PSU O
subjects O
who O
met O
criteria O
for O
stimulant O
use O
disorders O
were O
the O
following O
: O
53 O
% O
cocaine O
abuse O
, O
22 O
% O
cocaine O
dependence O
, O
42 O
% O
amphetamine O
abuse O
, O
and O
19 O
% O
amphetamine O
dependence O
( O
n=3 O
met O
criteria O
for O
2 O
symptoms O
of O
dependence O
, O
1 O
criterion O
short O
to O
obtain O
a O
diagnosis O
; O
n=20 O
met O
criteria O
for O
1 O
diagnosis O
; O
n=10 O
met O
criteria O
for O
2 O
diagnoses O
; O
and O
n=3 O
met O
criteria O
for O
3 O
diagnoses O
) O
. O

In O
comparison O
, O
DSU O
were O
defined O
as O
having O
: O
( O
1 O
) O
no O
6-month O
periods O
of O
3+ O
stimulant O
uses O
; O
and O
( O
2 O
) O
no O
interim O
stimulant O
use O
disorder O
symptoms O
. O

Figure O
1 O
illustrates O
that O
categorical O
analyses O
compared O
PSU O
and O
DSU O
on O
fMRI O
data O
, O
whereas O
dimensional O
analyses O
included O
all O
OSU O
with O
usable O
fMRI O
and O
follow-up O
data O
, O
even O
those O
who O
did O
not O
meet O
PSU O
or O
DSU O
group O
criteria O
. O

Categorical O
Analyses O
Self-report O
Group O
differences O
in O
age O
, O
verbal O
IQ O
, O
education O
, O
drug O
use O
sessions O
, O
impulsivity O
, O
and O
sensation O
seeking O
were O
evaluated O
using O
IBM O
SPSS O
Statistics O
for O
Windows O
Version O
22 O
( O
Armonk O
, O
NY O
) O
independent O
sample O
t-tests O
. O

Group O
differences O
in O
gender O
, O
handedness O
, O
race/ethnicity O
, O
depression O
( O
BDI O
scores O
0–9 O
= O
no O
depression O
; O
BDI O
scores O
10–14 O
= O
mild O
depression O
) O
and O
drug O
use O
recency O
were O
explored O
using O
SPSS O
chi-square O
tests O
. O

Neuroimaging O
For O
each O
voxel O
, O
a O
linear O
mixed O
effects O
( O
LME O
) O
model O
in O
R O
was O
calculated O
on O
PSC O
values O
with O
group O
( O
PSU O
, O
DSU O
) O
and O
decision O
condition O
( O
preferred O
, O
even O
, O
and O
worst O
choices O
) O
modeled O
as O
fixed O
factors O
, O
and O
subject O
modeled O
as O
a O
random O
factor O
. O

For O
each O
voxel O
, O
degrees O
of O
freedom O
, O
F O
, O
and O
p O
values O
were O
obtained O
for O
each O
main O
effect O
and O
interaction O
. O

Only O
individual O
voxels O
meeting O
p O
< O
.01 O
significance O
for O
the O
F O
test O
were O
considered O
for O
inclusion O
in O
brain O
clustering O
, O
correcting O
for O
multiple O
comparisons O
. O

Cohen O
’ O
s O
d O
was O
calculated O
to O
determine O
effect O
sizes O
. O

All O
fMRI O
results O
were O
whole-brain O
extractions O
. O

Dimensional O
Analyses O
Figure O
1 O
illustrates O
that O
across O
all O
OSU O
with O
usable O
follow-up O
data O
, O
regardless O
of O
group O
status O
, O
cumulative O
stimulant O
and O
marijuana O
uses O
at O
baseline O
as O
well O
as O
interim O
stimulant O
and O
marijuana O
uses O
reported O
at O
follow-up O
were O
log O
transformed O
due O
to O
skew O
, O
standardized O
, O
and O
entered O
as O
predictors O
in O
multivariate O
regressions O
for O
self-report O
and O
neuroimaging O
data O
. O

Self-report O
Multivariate O
linear O
regressions O
were O
computed O
in O
IBM O
SPSS O
Statistics O
for O
the O
following O
dependent O
variables O
: O
age O
, O
verbal O
IQ O
, O
education O
, O
impulsivity O
and O
sensation O
seeking O
. O

A O
multivariate O
logistic O
regression O
was O
computed O
for O
depression O
status O
. O

Neuroimaging O
A O
total O
of O
three O
multivariate O
linear O
regressions O
were O
computed O
in O
R O
( O
https O
: O
//cran.r-project.org/package=rlm O
) O
for O
each O
voxel O
in O
the O
whole-brain O
mask O
. O

Dependent O
variables O
were O
PSC O
for O
preferred O
, O
even O
, O
and O
worst O
decision O
trials O
. O

